<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: Drug Manufacturers - Other Industry News</title><link>http://biz.yahoo.com/ic/news/511.html</link><description>The latest news on the Drug Manufacturers - Other industry from Yahoo! Finance</description><language>en-US</language><lastBuildDate>Mon, 28 May 2012 18:34:44 GMT</lastBuildDate><image><url>http://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gif</url><title></title><link></link><width>144</width><height>45</height></image><item><title>5 Reasons To Buy Ironwood Pharmaceuticals</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12igc34fh/*http://seekingalpha.com/article/621271-5-reasons-to-buy-ironwood-pharmaceuticals?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/2806955995</guid><pubDate>Mon, 28 May 2012 18:34:44 GMT</pubDate></item><item><title>3 Health-Care Stocks Crushing the Market</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=1341pfh6k/*http://www.fool.com/investing/high-growth/2012/05/26/3-health-care-stocks-crushing-the-market.aspx?ticker=OREX&amp;source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/3298447654</guid><pubDate>Mon, 28 May 2012 14:26:12 GMT</pubDate></item><item><title>Is Teva Pharmaceuticals An &apos;Investment Classic&apos;?</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12megf93e/*http://seekingalpha.com/article/619431-is-teva-pharmaceuticals-an-investment-classic?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/1035126202</guid><pubDate>Sat, 26 May 2012 16:59:01 GMT</pubDate></item><item><title>ENDP Makes Bullish Cross Above Critical Moving Average</title><link>http://us.rd.yahoo.com/finance/external/forbes/rss/SIG=13grkrvja/*http://www.forbes.com/sites/dividendchannel/2012/05/25/endp-makes-bullish-cross-above-critical-moving-average/?partner=yahootix</link><description></description><guid isPermaLink="false">yahoo_finance/3266228901</guid><pubDate>Fri, 25 May 2012 20:27:19 GMT</pubDate></item><item><title>Apricus Biosciences Strengthens Vitaros(R) and Nexact(R) Patent Estate With Two New Patent Allowances</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/apricus-biosciences-strengthens-vitaros-r-172130884.html</link><description>[GlobeNewswire] - SAN DIEGO -- Apricus Biosciences, Inc. (&quot;Apricus Bio&quot; or the &quot;Company&quot;) (http://www.apricusbio.com) announced today that the Canadian Intellectual Property Office issued a Notice of ...</description><guid isPermaLink="false">yahoo_finance/133795198</guid><pubDate>Fri, 25 May 2012 17:21:30 GMT</pubDate></item><item><title>Endo Health Solutions Inc. to Present at Jefferies 2012 Global Healthcare Conference</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/endo-health-solutions-inc-present-170000525.html</link><description>[PR Newswire] - CHADDS FORD, Pa., May 25, 2012 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) today announced that Julie McHugh, chief operating officer, will present a corporate overview at the Jefferies 2012 ...</description><guid isPermaLink="false">yahoo_finance/1688261116</guid><pubDate>Fri, 25 May 2012 17:00:00 GMT</pubDate></item><item><title>Endo Health Solutions Inc. to Present at the Goldman Sachs 33rd Annual Global Healthcare Conference</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/endo-health-solutions-inc-present-170000178.html</link><description>[PR Newswire] - CHADDS FORD, Pa., May 25, 2012 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) today announced that Alan Levin, executive vice president and chief financial officer, will present a corporate ...</description><guid isPermaLink="false">yahoo_finance/558403402</guid><pubDate>Fri, 25 May 2012 17:00:00 GMT</pubDate></item><item><title>Dr. Reddy&apos;s Laboratories Should Continue To Gain Market Share In Lucrative Markets</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13qo0adje/*http://seekingalpha.com/article/618351-dr-reddy-s-laboratories-should-continue-to-gain-market-share-in-lucrative-markets?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/120316068</guid><pubDate>Fri, 25 May 2012 15:50:41 GMT</pubDate></item><item><title>Don&apos;t Get Too Worked Up Over The Medicines Company&apos;s Latest Numbers</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=13asbs59v/*http://www.fool.com/investing/general/2012/05/25/dont-get-too-worked-up-over-the-medicines-companys.aspx?ticker=MDCO&amp;source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/3174701012</guid><pubDate>Fri, 25 May 2012 15:30:07 GMT</pubDate></item><item><title>Goldman Pharma View: Buy AGN, Sell FRX, MRX A Takeover Target</title><link>http://us.rd.yahoo.com/finance/external/xbarronsblog/rss/SIG=13kcmj390/*http://blogs.barrons.com/stockstowatchtoday/2012/05/25/goldman-pharma-view-buy-agn-sell-frx-mrx-a-takeover-target/?mod=yahoobarrons</link><description></description><guid isPermaLink="false">yahoo_finance/3206990639</guid><pubDate>Fri, 25 May 2012 14:39:13 GMT</pubDate></item><item><title>Teva UK Limited Welcomes New NICE Pain Guidelines</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/teva-uk-limited-welcomes-nice-141900489.html</link><description>[PR Newswire] - CASTLEFORD, England, May 25, 2012 /PRNewswire/ --Teva UK Limited has welcomed recent clinical guidelines from the National Institute for Health and Clinical Excellence (NICE) on the use of strong opioids ...</description><guid isPermaLink="false">yahoo_finance/3984017423</guid><pubDate>Fri, 25 May 2012 14:19:00 GMT</pubDate></item><item><title>TB4 Provides Both Neuroprotection and Neurorestoration When Administered Shortly after Traumatic Brain Injury in Rat Model</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/tb4-provides-both-neuroprotection-neurorestoration-123000338.html</link><description></description><guid isPermaLink="false">yahoo_finance/4259189117</guid><pubDate>Fri, 25 May 2012 12:30:00 GMT</pubDate></item><item><title>Depomed To Present At Jefferies 2012 Global Health Care Conference</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/depomed-present-jefferies-2012-global-120000532.html</link><description>[PR Newswire] - MENLO PARK, Calif., May 25, 2012 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will be presenting at the Jefferies Global Health Care Conference in New York City.The presentation ...</description><guid isPermaLink="false">yahoo_finance/359627388</guid><pubDate>Fri, 25 May 2012 12:00:00 GMT</pubDate></item><item><title>This Just In: Upgrades and Downgrades</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12sinobdq/*http://www.fool.com/investing/general/2012/05/24/this-just-in-upgrades-and-downgrades.aspx?ticker=TEVA&amp;source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/2650821616</guid><pubDate>Fri, 25 May 2012 03:34:02 GMT</pubDate></item><item><title>Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/spectrum-pharmaceuticals-allos-therapeutics-announce-230600264.html</link><description>[Business Wire] - Spectrum Pharmaceuticals, Inc. and Allos Therapeutics, Inc. today announced that Spectrum has provided an additional extension of the offer period in connection with its tender offer to purchase all of the outstanding shares of common stock of Allos for $1.82 per share in cash, without interest and less any applicable withholding taxes, plus one Contingent Value Right, which entitles Allos stockholders ...</description><guid isPermaLink="false">yahoo_finance/3863269260</guid><pubDate>Thu, 24 May 2012 23:06:00 GMT</pubDate></item><item><title>Taro Provides Results for Three Months Ended March 2012</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/taro-provides-results-three-months-221000063.html</link><description>[Business Wire] - Taro Pharmaceutical Industries Ltd. today provided unaudited financial results for the three month period ended March 31, 2012.</description><guid isPermaLink="false">yahoo_finance/2867200904</guid><pubDate>Thu, 24 May 2012 22:10:00 GMT</pubDate></item><item><title>Warner Chilcott PLC (WCRX): Today&apos;s Featured Health Care Loser</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13bgirj0k/*http://www.thestreet.com/story/11553333/1/warner-chilcott-plc-wcrx-todays-featured-health-care-loser.html?puc=yahoo&amp;cm_ven=YAHOO</link><description></description><guid isPermaLink="false">yahoo_finance/3294190852</guid><pubDate>Thu, 24 May 2012 21:01:00 GMT</pubDate></item><item><title>Data for Amarin&apos;s AMR101 to be Presented at the National Lipid Association 2012 Annual Scientific Sessions</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/data-amarins-amr101-presented-national-202219731.html</link><description>[GlobeNewswire] - BEDMINSTER, N.J. and DUBLIN, Ireland -- Amarin Corporation plc , a late-stage biopharmaceutical company focused on cardiovascular disease, today announced that additional data from the AMR101 pivotal Phase ...</description><guid isPermaLink="false">yahoo_finance/624864343</guid><pubDate>Thu, 24 May 2012 20:22:19 GMT</pubDate></item><item><title>Teva cuts 2012 profit and sales forecasts</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/teva-cuts-2012-profit-sales-154328733.html</link><description></description><guid isPermaLink="false">yahoo_finance/2845800097</guid><pubDate>Thu, 24 May 2012 15:43:28 GMT</pubDate></item><item><title>Teva Cuts 2012 Guidance, But Stock Rises</title><link>http://us.rd.yahoo.com/finance/external/investors/rss/SIG=12nsbi6ms/*http://news.investors.com/article/612561/201205240829/teva-trims-outlook-for-2012.htm?ven=yahoocp&amp;ven=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/3055305634</guid><pubDate>Thu, 24 May 2012 15:29:00 GMT</pubDate></item><item><title>Synergy Pharma: Best Hidden Gem Of 2012</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12frn4njm/*http://seekingalpha.com/article/615601-synergy-pharma-best-hidden-gem-of-2012?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/199308998</guid><pubDate>Thu, 24 May 2012 15:28:17 GMT</pubDate></item></channel></rss><!-- c1.finance.sp2.yahoo.com compressed/chunked Tue May 29 01:48:18 UTC 2012 -->

